These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35717726)

  • 1. The effects of omega-3 fatty acids in type 2 diabetes: A systematic review and meta-analysis.
    Xiao Y; Zhang Q; Liao X; Elbelt U; Weylandt KH
    Prostaglandins Leukot Essent Fatty Acids; 2022 Jul; 182():102456. PubMed ID: 35717726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials.
    Wang Y; Wang Y; Shehzad Q; Su Y; Xu L; Yu L; Zeng W; Fang Z; Wu G; Wei W; Jin Q; Zhang H; Wang X
    Crit Rev Food Sci Nutr; 2023 May; ():1-28. PubMed ID: 37222574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial.
    Asghari KM; Saleh P; Salekzamani Y; Dolatkhah N; Aghamohammadzadeh N; Hashemian M
    Nutr Diabetes; 2024 Apr; 14(1):14. PubMed ID: 38589346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
    Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
    Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of medical plants from Zingiberaceae family on cardiovascular risk factors of type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
    Zhang X; Chen X; Tang Y; Guan X; Deng J; Fan J
    J Food Biochem; 2022 Jul; 46(7):e14130. PubMed ID: 35332564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of eicosapentaenoic acid and docosahexaenoic acid versus α-linolenic acid supplementation on cardiometabolic risk factors: a meta-analysis of randomized controlled trials.
    Chen H; Deng G; Zhou Q; Chu X; Su M; Wei Y; Li L; Zhang Z
    Food Funct; 2020 Mar; 11(3):1919-1932. PubMed ID: 32175534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-ratio n-6/n-3 PUFA on blood lipid level: a meta-analysis.
    Li N; Jia M; Deng Q; Wang Z; Huang F; Hou H; Xu T
    Hormones (Athens); 2021 Dec; 20(4):697-706. PubMed ID: 33123975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary eicosapentaenoic acid and docosahexaenoic acid supplementation on metabolic syndrome: A systematic review and meta-analysis of data from 33 randomized controlled trials.
    Zhang HJ; Gao X; Guo XF; Li KL; Li S; Sinclair AJ; Li D
    Clin Nutr; 2021 Jul; 40(7):4538-4550. PubMed ID: 34229258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
    Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
    Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
    Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
    Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.
    Poreba M; Mostowik M; Siniarski A; Golebiowska-Wiatrak R; Malinowski KP; Haberka M; Konduracka E; Nessler J; Undas A; Gajos G
    Cardiovasc Diabetol; 2017 Apr; 16(1):50. PubMed ID: 28410617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of omega-3 fatty acid supplementation on cardiovascular risk factors in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
    Xia Y; Wang Y; Cui M; Su D
    Ann Palliat Med; 2021 Jun; 10(6):6425-6437. PubMed ID: 34237964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Effects of Omega-3 Fatty Acids on Insulin Resistance and Lipid Profile in Maintenance Hemodialysis Patients: a Randomized Placebo-Controlled Trial.
    Gharekhani A; Dashti-Khavidaki S; Lessan-Pezeshki M; Khatami MR
    Iran J Kidney Dis; 2016 Sep; 10(5):310-318. PubMed ID: 27721230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis.
    Dai Y; Quan J; Xiong L; Luo Y; Yi B
    Ren Fail; 2022 Dec; 44(1):862-880. PubMed ID: 35611435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Omega-3 Polyunsaturated Fatty Acids Treatment on Lipid Pattern of HIV Patients: A Meta-Analysis of Randomized Clinical Trials.
    Fogacci F; Strocchi E; Veronesi M; Borghi C; Cicero AFG
    Mar Drugs; 2020 Jun; 18(6):. PubMed ID: 32492789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal plasma polyunsaturated fatty acid levels during pregnancy and childhood lipid and insulin levels.
    Vidakovic AJ; Jaddoe VW; Voortman T; Demmelmair H; Koletzko B; Gaillard R
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):78-85. PubMed ID: 27919543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
    Hartweg J; Perera R; Montori V; Dinneen S; Neil HA; Farmer A
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003205. PubMed ID: 18254017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
    Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
    Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of voglibose on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials.
    Nowrouzi-Sohrabi P; Tabrizi R; Rezaei S; Jafari F; Hessami K; Abedi M; Jalali M; Keshavarzi P; Shahabi S; Kolahi AA; Carson-Chahhoud K; Sahebkar A; Safiri S
    Pharmacol Res; 2020 Sep; 159():104988. PubMed ID: 32504833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.